DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0376358 | Malignant neoplasm of prostate | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0270853 | Juvenile Myoclonic Epilepsy | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0018802 | Congestive heart failure | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0002395 | Alzheimer's Disease | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0008370 | Cholestasis | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0011615 | Dermatitis, Atopic | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0036572 | Seizures | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0013595 | Eczema | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0001973 | Alcoholic Intoxication, Chronic | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0010346 | Crohn Disease | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C1839839 | MAJOR AFFECTIVE DISORDER 2 | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0018784 | Sensorineural Hearing Loss (disorder) | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C3536893 | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | NPL | 80896 | N-acetylneuraminate pyruvate lyase | Q9BXD5 |
C0086648 | MPS III B | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0038506 | Stuttering | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C2673377 | MUCOLIPIDOSIS II ALPHA/BETA (disorder) | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0476254 | Dyslexia | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0920296 | Developmental reading disorder | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0033788 | Pseudo-Hurler Polydystrophy | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0524851 | Neurodegenerative Disorders | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0026697 | Mucolipidoses | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0020725 | Type II Mucolipidosis | GNPTAB | 79158 | N-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Q3T906 |
C0033788 | Pseudo-Hurler Polydystrophy | GNPTAB | 79158 | N-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Q3T906 |
C0878544 | Cardiomyopathies | GNPTAB | 79158 | N-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Q3T906 |
C2673377 | MUCOLIPIDOSIS II ALPHA/BETA (disorder) | GNPTAB | 79158 | N-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Q3T906 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024